Copy to clipboard 
The 21 companies tracked in Exhibit 1 collectively grew +3.1% in 1Q18 vs. 1Q17, remaining on track alongside our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017.
Numerous players affirmed or updated their own full-year revenue guidance at the 1Q mark. For example, Globus Medical increased its numbers based on adoption of ExcelsiusGPS, K2M grew its range by $3MM following a distributor partnership and Orthofix upped guidance by about $9MM in acquisition-related contributions. After the quarter’s close, Wright Medical announced FDA premarket approval for AUGMENT injectable bone graft, and will update its full-year guidance in the 2Q18 call.
Exhibit 1: Orthopaedic Sales for Public Companies, As-Reported: 1Q18 vs. 1Q17 ($MM)
| Company | 1Q18 | 1Q17 | $ Chg | % Chg |
|---|---|---|---|---|
| Alphatec Spine | $21.3 | $28.0 | ($6.7) | (23.9%) |
| Anika | $19.5 | $20.2 | ($0.7) | (3.6%) |
| ConforMIS | $19.7 | $20.5 | ($0.8) | (3.9%) |
| ConMed | $108.9 | $103.8 | $5.1 | 4.9% |
| DePuy Synthes | $2,250.0 | $2,274.9 | ($24.9) | (1.1%) |
| DJO Surgical | $292.6 | $288.3 | $4.3 | 1.5% |
| Globus Medical | $174.4 | $155.8 | $18.6 | 11.9% |
| Integra | $24.8 | $26.1 | ($1.2) | (4.8%) |
| K2M | $67.9 | $61.9 | $6.0 | 9.6% |
| Mazor Robotics | $15.5 | $11.7 | $3.8 | 32.5% |
| Medtronic | $787.0 | $759.0 | $28.0 | 3.7% |
| NuVasive | $260.5 | $249.0 | $11.6 | 4.6% |
| Orthofix | $108.7 | $102.7 | $6.0 | 5.8% |
| OrthoPediatrics | $12.1 | $9.8 | $2.3 | 23.9% |
| SeaSpine | $33.2 | $31.9 | $1.3 | 4.1% |
| Smith & Nephew | $865.4 | $826.9 | $38.5 | 4.7% |
| Stryker | $1,724.9 | $1,612.3 | $112.6 | 7% |
| Vericel | $12.1 | $5.0 | $7.1 | 142% |
| Wright Medical | $198.5 | $177.2 | $21.3 | 12% |
| Xtant Medical | $17.9 | $22.1 | ($4.1) | (18.8%) |
| Zimmer Biomet | $1,856.6 | $1,816.9 | $39.7 | 2.2% |
Sources: Company press releases, websites, the U.S. Securities and Exchange Commission
Julie A. Vetalice is the Editorial Assistant for ORTHOWORLD. Reach her via email.
The 21 companies tracked in Exhibit 1 collectively grew +3.1% in 1Q18 vs. 1Q17, remaining on track alongside our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017.
Numerous players affirmed or updated their own full-year revenue guidance at the 1Q mark. For example, Globus Medical increased its numbers based on adoption of...
The 21 companies tracked in Exhibit 1 collectively grew +3.1% in 1Q18 vs. 1Q17, remaining on track alongside our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017.
Numerous players affirmed or updated their own full-year revenue guidance at the 1Q mark. For example, Globus Medical increased its numbers based on adoption of ExcelsiusGPS, K2M grew its range by $3MM following a distributor partnership and Orthofix upped guidance by about $9MM in acquisition-related contributions. After the quarter’s close, Wright Medical announced FDA premarket approval for AUGMENT injectable bone graft, and will update its full-year guidance in the 2Q18 call.
Exhibit 1: Orthopaedic Sales for Public Companies, As-Reported: 1Q18 vs. 1Q17 ($MM)
| Company | 1Q18 | 1Q17 | $ Chg | % Chg |
|---|---|---|---|---|
| Alphatec Spine | $21.3 | $28.0 | ($6.7) | (23.9%) |
| Anika | $19.5 | $20.2 | ($0.7) | (3.6%) |
| ConforMIS | $19.7 | $20.5 | ($0.8) | (3.9%) |
| ConMed | $108.9 | $103.8 | $5.1 | 4.9% |
| DePuy Synthes | $2,250.0 | $2,274.9 | ($24.9) | (1.1%) |
| DJO Surgical | $292.6 | $288.3 | $4.3 | 1.5% |
| Globus Medical | $174.4 | $155.8 | $18.6 | 11.9% |
| Integra | $24.8 | $26.1 | ($1.2) | (4.8%) |
| K2M | $67.9 | $61.9 | $6.0 | 9.6% |
| Mazor Robotics | $15.5 | $11.7 | $3.8 | 32.5% |
| Medtronic | $787.0 | $759.0 | $28.0 | 3.7% |
| NuVasive | $260.5 | $249.0 | $11.6 | 4.6% |
| Orthofix | $108.7 | $102.7 | $6.0 | 5.8% |
| OrthoPediatrics | $12.1 | $9.8 | $2.3 | 23.9% |
| SeaSpine | $33.2 | $31.9 | $1.3 | 4.1% |
| Smith & Nephew | $865.4 | $826.9 | $38.5 | 4.7% |
| Stryker | $1,724.9 | $1,612.3 | $112.6 | 7% |
| Vericel | $12.1 | $5.0 | $7.1 | 142% |
| Wright Medical | $198.5 | $177.2 | $21.3 | 12% |
| Xtant Medical | $17.9 | $22.1 | ($4.1) | (18.8%) |
| Zimmer Biomet | $1,856.6 | $1,816.9 | $39.7 | 2.2% |
Sources: Company press releases, websites, the U.S. Securities and Exchange Commission
Julie A. Vetalice is the Editorial Assistant for ORTHOWORLD. Reach her via email.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
